fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
fincash number+91-22-48913909
2021 के शीर्ष 10 इक्विटी म्युचुअल फंड | प्रदर्शन मूल्यांकन

फिनकैश »म्यूचुअल फंड्स »बेस्ट परफॉर्मिंग इक्विटी फंड्स 2018

2021 के सर्वश्रेष्ठ इक्विटी म्युचुअल फंड

Updated on June 29, 2025 , 715 views

इक्विटी फंड वे हैं जिनके संचित फंड का पैसा विभिन्न कंपनियों के इक्विटी और इक्विटी से संबंधित उपकरणों में निवेश किया जाता है। मध्यम और उच्च स्तर वाले लोगों के लिए इक्विटी फंड को दीर्घकालिक निवेश विकल्प माना जाता है।जोखिम उठाने का माद्दा. इक्विटी फंड की विभिन्न श्रेणियों में शामिल हैंलार्ज कैप फंड,मिड कैप फंड,स्मॉल कैप फंड,ईएलएसएस, और इसी तरह। वर्ष 2021 में, इक्विटी बाजारों में तेजी देखी गई, जिसके कारण अधिकांश इक्विटी फंड श्रेणियों ने अच्छा प्रदर्शन किया है। इन फंडों का प्रदर्शन बहुत सारे मैक्रो और माइक्रोइकॉनॉमिक मापदंडों पर निर्भर करता है जैसे कि उद्योग का प्रदर्शन, कंपनी का प्रदर्शन, कंपनियों की कमाई और मुनाफा, इसकी भविष्य की संभावनाएं, और इसी तरह। शीर्ष औरसर्वश्रेष्ठ इक्विटी फंड वर्ष 2021 के लिए इस प्रकार हैं।

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

प्रदर्शन के आधार पर 2021 के शीर्ष 10 इक्विटी म्यूचुअल फंड

FundNAVNet Assets (Cr)2024 (%)2023 (%)2022 (%)2021 (%)2020 (%)
Motilal Oswal Midcap 30 Fund  Growth ₹104.651
↑ 0.01
₹30,40157.141.710.755.89.3
LIC MF Infrastructure Fund Growth ₹50.7897
↑ 0.01
₹1,00547.844.47.946.6-0.1
Motilal Oswal Long Term Equity Fund Growth ₹53.3884
↓ -0.05
₹4,36047.7371.832.18.8
Motilal Oswal Multicap 35 Fund Growth ₹63.4987
↓ -0.04
₹13,02345.731-315.310.3
Invesco India Mid Cap Fund Growth ₹181.14
↓ -0.14
₹6,64143.134.10.543.124.4
UTI Healthcare Fund Growth ₹284.954
↓ -1.14
₹1,06242.938.2-12.319.167.4
SBI Healthcare Opportunities Fund Growth ₹432.453
↑ 4.56
₹3,68942.238.2-620.165.8
TATA India Pharma & Healthcare Fund Growth ₹30.0908
↓ -0.11
₹1,23240.436.6-819.164.4
IDBI Small Cap Fund Growth ₹30.585
↑ 0.00
₹5764033.42.464.719
L&T Midcap Fund Growth ₹395.818
↓ -0.11
₹11,47039.7401.130.419
Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 1 Jul 25

2021 के शीर्ष और सर्वश्रेष्ठ इक्विटी म्युचुअल फंड

1. Motilal Oswal Midcap 30 Fund 

(Erstwhile Motilal Oswal MOSt Focused Midcap 30 Fund)

The investment objective of the Scheme is to achieve long term capital appreciation by investing in a maximum of 30 quality mid-cap companies having long-term competitive advantages and potential for growth. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

Motilal Oswal Midcap 30 Fund  is a Equity - Mid Cap fund was launched on 24 Feb 14. It is a fund with Moderately High risk and has given a CAGR/Annualized return of 23% since its launch.  Ranked 27 in Mid Cap category.  Return for 2024 was 57.1% , 2023 was 41.7% and 2022 was 10.7% .

Below is the key information for Motilal Oswal Midcap 30 Fund 

Motilal Oswal Midcap 30 Fund 
Growth
Launch Date 24 Feb 14
NAV (01 Jul 25) ₹104.651 ↑ 0.01   (0.01 %)
Net Assets (Cr) ₹30,401 on 31 May 25
Category Equity - Mid Cap
AMC Motilal Oswal Asset Management Co. Ltd
Rating
Risk Moderately High
Expense Ratio 0.66
Sharpe Ratio 0.56
Information Ratio 0.47
Alpha Ratio 9.44
Min Investment 5,000
Min SIP Investment 500
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

DateValue
30 Jun 20₹10,000
30 Jun 21₹16,285
30 Jun 22₹19,393
30 Jun 23₹26,738
30 Jun 24₹43,870
30 Jun 25₹48,048

Motilal Oswal Midcap 30 Fund  SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹738,840.
Net Profit of ₹438,840
Invest Now

Returns for Motilal Oswal Midcap 30 Fund 

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 1 Jul 25

DurationReturns
1 Month 5%
3 Month 14.6%
6 Month -7.2%
1 Year 8.9%
3 Year 35.4%
5 Year 36.9%
10 Year
15 Year
Since launch 23%
Historical performance (Yearly) on absolute basis
YearReturns
2024 57.1%
2023 41.7%
2022 10.7%
2021 55.8%
2020 9.3%
2019 9.7%
2018 -12.7%
2017 30.8%
2016 5.2%
2015 16.5%
Fund Manager information for Motilal Oswal Midcap 30 Fund 
NameSinceTenure
Ajay Khandelwal1 Oct 240.67 Yr.
Niket Shah1 Jul 204.92 Yr.
Rakesh Shetty22 Nov 222.53 Yr.
Sunil Sawant1 Jul 240.92 Yr.

Data below for Motilal Oswal Midcap 30 Fund  as on 31 May 25

Equity Sector Allocation
SectorValue
Technology29.87%
Consumer Cyclical16.01%
Industrials15.27%
Health Care4.44%
Communication Services4.06%
Real Estate2.81%
Basic Materials2%
Utility0.24%
Financial Services0.09%
Asset Allocation
Asset ClassValue
Cash31.18%
Equity68.82%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Coforge Ltd (Technology)
Equity, Since 31 Mar 23 | COFORGE
10%₹3,078 Cr3,600,000
Persistent Systems Ltd (Technology)
Equity, Since 31 Jan 23 | PERSISTENT
10%₹2,960 Cr5,250,000
Kalyan Jewellers India Ltd (Consumer Cyclical)
Equity, Since 29 Feb 24 | KALYANKJIL
8%₹2,437 Cr43,490,250
Polycab India Ltd (Industrials)
Equity, Since 30 Sep 23 | POLYCAB
5%₹1,498 Cr2,500,000
Bharti Hexacom Ltd (Communication Services)
Equity, Since 31 Oct 24 | BHARTIHEXA
4%₹1,236 Cr6,750,000
↑ 250,000
Dixon Technologies (India) Ltd (Technology)
Equity, Since 31 Mar 23 | DIXON
4%₹1,227 Cr835,200
↑ 100,000
Trent Ltd (Consumer Cyclical)
Equity, Since 30 Nov 24 | TRENT
4%₹1,210 Cr2,143,194
↑ 7,450
One97 Communications Ltd (Technology)
Equity, Since 30 Sep 24 | 543396
4%₹1,149 Cr12,900,814
↑ 512,314
Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 24 | MAXHEALTH
4%₹1,122 Cr9,969,361
KEI Industries Ltd (Industrials)
Equity, Since 30 Nov 24 | KEI
3%₹993 Cr2,750,000
↑ 50,000

2. LIC MF Infrastructure Fund

The investment objective of the scheme is to provide long term growth from a portfolio of equity / equity related instruments of companies engaged either directly or indirectly in the infrastructure sector.

LIC MF Infrastructure Fund is a Equity - Sectoral fund was launched on 29 Feb 08. It is a fund with High risk and has given a CAGR/Annualized return of 9.8% since its launch.  Return for 2024 was 47.8% , 2023 was 44.4% and 2022 was 7.9% .

Below is the key information for LIC MF Infrastructure Fund

LIC MF Infrastructure Fund
Growth
Launch Date 29 Feb 08
NAV (01 Jul 25) ₹50.7897 ↑ 0.01   (0.02 %)
Net Assets (Cr) ₹1,005 on 31 May 25
Category Equity - Sectoral
AMC LIC Mutual Fund Asset Mgmt Co Ltd
Rating Not Rated
Risk High
Expense Ratio 2.3
Sharpe Ratio 0.2
Information Ratio 0.54
Alpha Ratio 6.66
Min Investment 5,000
Min SIP Investment 1,000
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

DateValue
30 Jun 20₹10,000
30 Jun 21₹15,983
30 Jun 22₹17,801
30 Jun 23₹22,663
30 Jun 24₹41,985
30 Jun 25₹42,989

LIC MF Infrastructure Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹689,048.
Net Profit of ₹389,048
Invest Now

Returns for LIC MF Infrastructure Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 1 Jul 25

DurationReturns
1 Month 3.3%
3 Month 17.2%
6 Month -1.8%
1 Year 0.5%
3 Year 34.2%
5 Year 33.5%
10 Year
15 Year
Since launch 9.8%
Historical performance (Yearly) on absolute basis
YearReturns
2024 47.8%
2023 44.4%
2022 7.9%
2021 46.6%
2020 -0.1%
2019 13.3%
2018 -14.6%
2017 42.2%
2016 -2.2%
2015 -6.2%
Fund Manager information for LIC MF Infrastructure Fund
NameSinceTenure
Yogesh Patil18 Sep 204.7 Yr.
Mahesh Bendre1 Jul 240.92 Yr.

Data below for LIC MF Infrastructure Fund as on 31 May 25

Equity Sector Allocation
SectorValue
Industrials51.57%
Basic Materials9.67%
Consumer Cyclical7.9%
Utility6.15%
Financial Services5.44%
Real Estate2.87%
Communication Services2.32%
Technology2.25%
Health Care0.42%
Energy0.4%
Asset Allocation
Asset ClassValue
Cash10.86%
Equity89.14%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Garware Hi-Tech Films Ltd (Basic Materials)
Equity, Since 31 Aug 23 | 500655
4%₹44 Cr94,287
Shakti Pumps (India) Ltd (Industrials)
Equity, Since 31 Mar 24 | SHAKTIPUMP
4%₹39 Cr452,572
↑ 44,445
Tata Power Co Ltd (Utilities)
Equity, Since 29 Feb 24 | TATAPOWER
3%₹28 Cr724,927
Afcons Infrastructure Ltd (Industrials)
Equity, Since 31 Oct 24 | AFCONS
3%₹26 Cr624,435
↑ 87,219
Bharat Heavy Electricals Ltd (Industrials)
Equity, Since 31 May 24 | BHEL
2%₹24 Cr913,126
↓ -149,073
Schneider Electric Infrastructure Ltd (Industrials)
Equity, Since 31 Dec 23 | SCHNEIDER
2%₹23 Cr305,924
↓ -26,125
REC Ltd (Financial Services)
Equity, Since 31 Jul 23 | RECLTD
2%₹23 Cr571,332
Cummins India Ltd (Industrials)
Equity, Since 31 May 21 | CUMMINSIND
2%₹22 Cr67,407
↑ 559
GE Vernova T&D India Ltd (Industrials)
Equity, Since 31 Jan 24 | 522275
2%₹22 Cr96,061
↓ -30,853
TD Power Systems Ltd (Industrials)
Equity, Since 30 Apr 23 | TDPOWERSYS
2%₹21 Cr397,031
↓ -79,438

3. Motilal Oswal Long Term Equity Fund

(Erstwhile Motilal Oswal MOSt Focused Long Term Fund)

The investment objective of the Scheme is to generate long-term capital appreciation from a diversified portfolio of predominantly equity and equity related instruments. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

Motilal Oswal Long Term Equity Fund is a Equity - ELSS fund was launched on 21 Jan 15. It is a fund with Moderately High risk and has given a CAGR/Annualized return of 17.4% since its launch.  Return for 2024 was 47.7% , 2023 was 37% and 2022 was 1.8% .

Below is the key information for Motilal Oswal Long Term Equity Fund

Motilal Oswal Long Term Equity Fund
Growth
Launch Date 21 Jan 15
NAV (01 Jul 25) ₹53.3884 ↓ -0.05   (-0.10 %)
Net Assets (Cr) ₹4,360 on 31 May 25
Category Equity - ELSS
AMC Motilal Oswal Asset Management Co. Ltd
Rating Not Rated
Risk Moderately High
Expense Ratio 0.74
Sharpe Ratio 0.44
Information Ratio 0.98
Alpha Ratio 7.68
Min Investment 500
Min SIP Investment 500
Exit Load NIL

Growth of 10,000 investment over the years.

DateValue
30 Jun 20₹10,000
30 Jun 21₹15,667
30 Jun 22₹14,668
30 Jun 23₹19,681
30 Jun 24₹31,051
30 Jun 25₹34,307

Motilal Oswal Long Term Equity Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹598,181.
Net Profit of ₹298,181
Invest Now

Returns for Motilal Oswal Long Term Equity Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 1 Jul 25

DurationReturns
1 Month 3%
3 Month 18.9%
6 Month -4.7%
1 Year 9.8%
3 Year 32.3%
5 Year 27.9%
10 Year
15 Year
Since launch 17.4%
Historical performance (Yearly) on absolute basis
YearReturns
2024 47.7%
2023 37%
2022 1.8%
2021 32.1%
2020 8.8%
2019 13.2%
2018 -8.7%
2017 44%
2016 12.5%
2015
Fund Manager information for Motilal Oswal Long Term Equity Fund
NameSinceTenure
Ajay Khandelwal11 Dec 231.47 Yr.
Rakesh Shetty22 Nov 222.53 Yr.
Atul Mehra1 Oct 240.67 Yr.

Data below for Motilal Oswal Long Term Equity Fund as on 31 May 25

Equity Sector Allocation
SectorValue
Industrials37.3%
Consumer Cyclical20.59%
Financial Services17.43%
Technology8.6%
Real Estate6.27%
Basic Materials5.67%
Health Care2.96%
Asset Allocation
Asset ClassValue
Cash1.18%
Equity98.82%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Trent Ltd (Consumer Cyclical)
Equity, Since 31 Aug 22 | TRENT
6%₹240 Cr425,260
Eternal Ltd (Consumer Cyclical)
Equity, Since 31 Oct 23 | 543320
5%₹236 Cr9,923,692
Bharat Dynamics Ltd Ordinary Shares (Industrials)
Equity, Since 31 Dec 23 | BDL
5%₹213 Cr1,056,315
Kaynes Technology India Ltd (Industrials)
Equity, Since 30 Jun 23 | KAYNES
4%₹178 Cr297,751
Suzlon Energy Ltd (Industrials)
Equity, Since 31 Jan 24 | SUZLON
4%₹177 Cr24,702,337
Inox Wind Ltd (Industrials)
Equity, Since 31 Dec 23 | 539083
4%₹159 Cr8,173,777
Amber Enterprises India Ltd Ordinary Shares (Consumer Cyclical)
Equity, Since 31 Mar 24 | AMBER
4%₹156 Cr240,350
Multi Commodity Exchange of India Ltd (Financial Services)
Equity, Since 29 Feb 24 | MCX
4%₹155 Cr235,083
Prestige Estates Projects Ltd (Real Estate)
Equity, Since 31 Oct 23 | PRESTIGE
4%₹155 Cr1,055,205
Bharat Electronics Ltd (Industrials)
Equity, Since 30 Apr 24 | BEL
3%₹152 Cr3,950,000

4. Motilal Oswal Multicap 35 Fund

(Erstwhile Motilal Oswal MOSt Focused Multicap 35 Fund)

The investment objective of the Scheme is to achieve long term capital appreciation by primarily investing in a maximum of 35 equity & equity related instruments across sectors and market-capitalization levels.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

Motilal Oswal Multicap 35 Fund is a Equity - Multi Cap fund was launched on 28 Apr 14. It is a fund with Moderately High risk and has given a CAGR/Annualized return of 18% since its launch.  Ranked 5 in Multi Cap category.  Return for 2024 was 45.7% , 2023 was 31% and 2022 was -3% .

Below is the key information for Motilal Oswal Multicap 35 Fund

Motilal Oswal Multicap 35 Fund
Growth
Launch Date 28 Apr 14
NAV (01 Jul 25) ₹63.4987 ↓ -0.04   (-0.06 %)
Net Assets (Cr) ₹13,023 on 31 May 25
Category Equity - Multi Cap
AMC Motilal Oswal Asset Management Co. Ltd
Rating
Risk Moderately High
Expense Ratio 0.94
Sharpe Ratio 0.6
Information Ratio 0.67
Alpha Ratio 9.7
Min Investment 5,000
Min SIP Investment 500
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

DateValue
30 Jun 20₹10,000
30 Jun 21₹14,465
30 Jun 22₹12,910
30 Jun 23₹15,538
30 Jun 24₹24,143
30 Jun 25₹27,563

Motilal Oswal Multicap 35 Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹530,691.
Net Profit of ₹230,691
Invest Now

Returns for Motilal Oswal Multicap 35 Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 1 Jul 25

DurationReturns
1 Month 5.9%
3 Month 11.4%
6 Month -0.5%
1 Year 14.2%
3 Year 28.8%
5 Year 22.5%
10 Year
15 Year
Since launch 18%
Historical performance (Yearly) on absolute basis
YearReturns
2024 45.7%
2023 31%
2022 -3%
2021 15.3%
2020 10.3%
2019 7.9%
2018 -7.8%
2017 43.1%
2016 8.5%
2015 14.6%
Fund Manager information for Motilal Oswal Multicap 35 Fund
NameSinceTenure
Ajay Khandelwal1 Oct 240.67 Yr.
Niket Shah1 Jul 222.92 Yr.
Rakesh Shetty22 Nov 222.53 Yr.
Atul Mehra1 Oct 240.67 Yr.
Sunil Sawant1 Jul 240.92 Yr.

Data below for Motilal Oswal Multicap 35 Fund as on 31 May 25

Equity Sector Allocation
SectorValue
Technology22.43%
Industrials18.22%
Consumer Cyclical17.08%
Financial Services8.53%
Communication Services8.52%
Health Care1.73%
Consumer Defensive0.54%
Asset Allocation
Asset ClassValue
Cash23.56%
Equity76.44%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Coforge Ltd (Technology)
Equity, Since 31 May 23 | COFORGE
11%₹1,389 Cr1,625,000
↓ -100,000
Persistent Systems Ltd (Technology)
Equity, Since 31 Mar 23 | PERSISTENT
10%₹1,240 Cr2,200,000
Polycab India Ltd (Industrials)
Equity, Since 31 Jan 24 | POLYCAB
9%₹1,164 Cr1,942,305
↓ -57,570
Kalyan Jewellers India Ltd (Consumer Cyclical)
Equity, Since 30 Sep 23 | KALYANKJIL
8%₹1,009 Cr18,000,000
↑ 114,380
CG Power & Industrial Solutions Ltd (Industrials)
Equity, Since 31 Jan 25 | CGPOWER
6%₹841 Cr12,250,000
↑ 175,830
Trent Ltd (Consumer Cyclical)
Equity, Since 31 Jan 23 | TRENT
6%₹787 Cr1,394,889
Cholamandalam Investment and Finance Co Ltd (Financial Services)
Equity, Since 31 Mar 23 | CHOLAFIN
6%₹720 Cr4,500,000
Bharti Airtel Ltd (Partly Paid Rs.1.25) (Communication Services)
Equity, Since 30 Apr 24 | 890157
5%₹701 Cr4,999,500
Eternal Ltd (Consumer Cyclical)
Equity, Since 31 May 25 | 543320
3%₹413 Cr17,331,906
↑ 17,331,906
Bharti Airtel Ltd (Communication Services)
Equity, Since 31 May 25 | BHARTIARTL
3%₹409 Cr2,200,826
↑ 2,200,826

5. Invesco India Mid Cap Fund

The Scheme seeks to provide long term capital appreciation by investing in a portfolio that is predominantly constituted of equity and equity related instruments of mid cap companies. However, there can be no assurance that the funds objectives will be achieved.

Invesco India Mid Cap Fund is a Equity - Mid Cap fund was launched on 19 Apr 07. It is a fund with Moderately High risk and has given a CAGR/Annualized return of 17.3% since its launch.  Ranked 38 in Mid Cap category.  Return for 2024 was 43.1% , 2023 was 34.1% and 2022 was 0.5% .

Below is the key information for Invesco India Mid Cap Fund

Invesco India Mid Cap Fund
Growth
Launch Date 19 Apr 07
NAV (01 Jul 25) ₹181.14 ↓ -0.14   (-0.08 %)
Net Assets (Cr) ₹6,641 on 31 May 25
Category Equity - Mid Cap
AMC Invesco Asset Management (India) Private Ltd
Rating
Risk Moderately High
Expense Ratio 1.89
Sharpe Ratio 0.69
Information Ratio 0
Alpha Ratio 0
Min Investment 5,000
Min SIP Investment 500
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

DateValue
30 Jun 20₹10,000
30 Jun 21₹16,589
30 Jun 22₹16,322
30 Jun 23₹21,366
30 Jun 24₹33,031
30 Jun 25₹38,743

Invesco India Mid Cap Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹657,502.
Net Profit of ₹357,502
Invest Now

Returns for Invesco India Mid Cap Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 1 Jul 25

DurationReturns
1 Month 7.1%
3 Month 18.5%
6 Month 5.1%
1 Year 17.3%
3 Year 33.4%
5 Year 31.1%
10 Year
15 Year
Since launch 17.3%
Historical performance (Yearly) on absolute basis
YearReturns
2024 43.1%
2023 34.1%
2022 0.5%
2021 43.1%
2020 24.4%
2019 3.8%
2018 -5.3%
2017 44.3%
2016 1.1%
2015 6.4%
Fund Manager information for Invesco India Mid Cap Fund
NameSinceTenure
Aditya Khemani9 Nov 231.56 Yr.
Amit Ganatra1 Sep 231.75 Yr.

Data below for Invesco India Mid Cap Fund as on 31 May 25

Equity Sector Allocation
SectorValue
Financial Services27.03%
Health Care17.76%
Consumer Cyclical15.55%
Industrials11.63%
Technology9.53%
Real Estate7.96%
Basic Materials7.71%
Communication Services1.94%
Asset Allocation
Asset ClassValue
Cash0.89%
Equity99.11%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
BSE Ltd (Financial Services)
Equity, Since 31 Dec 23 | BSE
6%₹406 Cr1,519,233
L&T Finance Ltd (Financial Services)
Equity, Since 31 Dec 23 | LTF
4%₹289 Cr16,854,973
Prestige Estates Projects Ltd (Real Estate)
Equity, Since 30 Nov 23 | PRESTIGE
4%₹278 Cr1,893,617
Max Financial Services Ltd (Financial Services)
Equity, Since 30 Nov 23 | MFSL
4%₹270 Cr1,798,532
↑ 114,429
The Federal Bank Ltd (Financial Services)
Equity, Since 31 Oct 22 | FEDERALBNK
4%₹258 Cr12,745,942
↑ 239,160
Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Dec 22 | MAXHEALTH
4%₹253 Cr2,246,434
Trent Ltd (Consumer Cyclical)
Equity, Since 30 Apr 21 | TRENT
4%₹249 Cr441,151
JK Cement Ltd (Basic Materials)
Equity, Since 31 Oct 22 | JKCEMENT
4%₹237 Cr431,234
Dixon Technologies (India) Ltd (Technology)
Equity, Since 28 Feb 22 | DIXON
3%₹228 Cr155,335
HDFC Asset Management Co Ltd (Financial Services)
Equity, Since 31 Jan 25 | HDFCAMC
3%₹210 Cr439,084

6. UTI Healthcare Fund

(Erstwhile UTI Pharma & Healthcare Fund)

The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors.

UTI Healthcare Fund is a Equity - Sectoral fund was launched on 28 Jun 99. It is a fund with High risk and has given a CAGR/Annualized return of 15% since its launch.  Ranked 40 in Sectoral category.  Return for 2024 was 42.9% , 2023 was 38.2% and 2022 was -12.3% .

Below is the key information for UTI Healthcare Fund

UTI Healthcare Fund
Growth
Launch Date 28 Jun 99
NAV (01 Jul 25) ₹284.954 ↓ -1.14   (-0.40 %)
Net Assets (Cr) ₹1,062 on 31 May 25
Category Equity - Sectoral
AMC UTI Asset Management Company Ltd
Rating
Risk High
Expense Ratio 2.38
Sharpe Ratio 0.83
Information Ratio -0.11
Alpha Ratio 0.87
Min Investment 5,000
Min SIP Investment 500
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

DateValue
30 Jun 20₹10,000
30 Jun 21₹15,774
30 Jun 22₹13,373
30 Jun 23₹15,783
30 Jun 24₹22,500
30 Jun 25₹27,347

UTI Healthcare Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹530,691.
Net Profit of ₹230,691
Invest Now

Returns for UTI Healthcare Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 1 Jul 25

DurationReturns
1 Month 3.4%
3 Month 6.7%
6 Month -2.4%
1 Year 21.5%
3 Year 26.9%
5 Year 22.3%
10 Year
15 Year
Since launch 15%
Historical performance (Yearly) on absolute basis
YearReturns
2024 42.9%
2023 38.2%
2022 -12.3%
2021 19.1%
2020 67.4%
2019 1.2%
2018 -7.5%
2017 6.2%
2016 -9.7%
2015 12.4%
Fund Manager information for UTI Healthcare Fund
NameSinceTenure
Kamal Gada2 May 223.08 Yr.

Data below for UTI Healthcare Fund as on 31 May 25

Equity Sector Allocation
SectorValue
Health Care96.34%
Basic Materials0.99%
Asset Allocation
Asset ClassValue
Cash2.67%
Equity97.33%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA
10%₹111 Cr661,016
↓ -11,873
Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | CIPLA
6%₹59 Cr400,000
Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDY
5%₹50 Cr396,000
Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Dec 20 | PGHL
4%₹46 Cr80,283
↑ 520
Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | AJANTPHARM
4%₹43 Cr172,829
Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | GLENMARK
4%₹40 Cr275,250
Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSP
4%₹39 Cr56,271
Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB
3%₹37 Cr56,000
Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Dec 20 | FORTIS
3%₹33 Cr465,000
Eris Lifesciences Ltd Registered Shs (Healthcare)
Equity, Since 31 Mar 19 | ERIS
3%₹32 Cr204,451
↓ -8,479

7. SBI Healthcare Opportunities Fund

(Erstwhile SBI Pharma Fund)

To provide the investors maximum growth opportunity through equity investments in stocks of growth oriented sectors of the economy.

SBI Healthcare Opportunities Fund is a Equity - Sectoral fund was launched on 31 Dec 04. It is a fund with High risk and has given a CAGR/Annualized return of 15.6% since its launch.  Ranked 34 in Sectoral category.  Return for 2024 was 42.2% , 2023 was 38.2% and 2022 was -6% .

Below is the key information for SBI Healthcare Opportunities Fund

SBI Healthcare Opportunities Fund
Growth
Launch Date 31 Dec 04
NAV (30 Jun 25) ₹432.453 ↑ 4.56   (1.06 %)
Net Assets (Cr) ₹3,689 on 31 May 25
Category Equity - Sectoral
AMC SBI Funds Management Private Limited
Rating
Risk High
Expense Ratio 2.09
Sharpe Ratio 0.97
Information Ratio 0.52
Alpha Ratio 2.81
Min Investment 5,000
Min SIP Investment 500
Exit Load 0-15 Days (0.5%),15 Days and above(NIL)

Growth of 10,000 investment over the years.

DateValue
30 Jun 20₹10,000
30 Jun 21₹15,902
30 Jun 22₹13,774
30 Jun 23₹17,755
30 Jun 24₹24,634
30 Jun 25₹29,799

SBI Healthcare Opportunities Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹556,833.
Net Profit of ₹256,833
Invest Now

Returns for SBI Healthcare Opportunities Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 1 Jul 25

DurationReturns
1 Month 3.4%
3 Month 5.2%
6 Month -1%
1 Year 21%
3 Year 29.3%
5 Year 24.4%
10 Year
15 Year
Since launch 15.6%
Historical performance (Yearly) on absolute basis
YearReturns
2024 42.2%
2023 38.2%
2022 -6%
2021 20.1%
2020 65.8%
2019 -0.5%
2018 -9.9%
2017 2.1%
2016 -14%
2015 27.1%
Fund Manager information for SBI Healthcare Opportunities Fund
NameSinceTenure
Tanmaya Desai1 Jun 1114.01 Yr.

Data below for SBI Healthcare Opportunities Fund as on 31 May 25

Equity Sector Allocation
SectorValue
Health Care90.06%
Basic Materials6.02%
Asset Allocation
Asset ClassValue
Cash3.92%
Equity96.08%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMA
13%₹470 Cr2,800,000
Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB
7%₹273 Cr412,222
↑ 12,222
Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 21 | MAXHEALTH
6%₹236 Cr2,100,000
Lonza Group Ltd ADR (Healthcare)
Equity, Since 31 Jan 24 | LZAGY
5%₹178 Cr300,000
Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | CIPLA
5%₹176 Cr1,200,000
Lupin Ltd (Healthcare)
Equity, Since 31 Aug 23 | LUPIN
4%₹164 Cr840,000
Mankind Pharma Ltd (Healthcare)
Equity, Since 30 Apr 23 | MANKIND
4%₹138 Cr560,000
Krishna Institute of Medical Sciences Ltd (Healthcare)
Equity, Since 30 Nov 22 | 543308
3%₹123 Cr1,800,000
↓ -234,372
Fortis Healthcare Ltd (Healthcare)
Equity, Since 30 Apr 21 | FORTIS
3%₹119 Cr1,680,000
Acutaas Chemicals Ltd (Basic Materials)
Equity, Since 30 Jun 24 | 543349
3%₹118 Cr1,000,000

8. TATA India Pharma & Healthcare Fund

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

TATA India Pharma & Healthcare Fund is a Equity - Sectoral fund was launched on 28 Dec 15. It is a fund with High risk and has given a CAGR/Annualized return of 12.3% since its launch.  Return for 2024 was 40.4% , 2023 was 36.6% and 2022 was -8% .

Below is the key information for TATA India Pharma & Healthcare Fund

TATA India Pharma & Healthcare Fund
Growth
Launch Date 28 Dec 15
NAV (01 Jul 25) ₹30.0908 ↓ -0.11   (-0.35 %)
Net Assets (Cr) ₹1,232 on 31 May 25
Category Equity - Sectoral
AMC Tata Asset Management Limited
Rating Not Rated
Risk High
Expense Ratio 0
Sharpe Ratio 0.54
Information Ratio 0.74
Alpha Ratio 1.9
Min Investment 5,000
Min SIP Investment 150
Exit Load 0-3 Months (0.25%),3 Months and above(NIL)

Growth of 10,000 investment over the years.

DateValue
30 Jun 20₹10,000
30 Jun 21₹15,403
30 Jun 22₹13,787
30 Jun 23₹16,370
30 Jun 24₹23,471
30 Jun 25₹27,032

TATA India Pharma & Healthcare Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹530,691.
Net Profit of ₹230,691
Invest Now

Returns for TATA India Pharma & Healthcare Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 1 Jul 25

DurationReturns
1 Month 2.9%
3 Month 6.2%
6 Month -5.6%
1 Year 14.5%
3 Year 24.7%
5 Year 22.1%
10 Year
15 Year
Since launch 12.3%
Historical performance (Yearly) on absolute basis
YearReturns
2024 40.4%
2023 36.6%
2022 -8%
2021 19.1%
2020 64.4%
2019 5.5%
2018 -2.6%
2017 4.7%
2016 -14.7%
2015
Fund Manager information for TATA India Pharma & Healthcare Fund
NameSinceTenure
Meeta Shetty9 Mar 214.23 Yr.
Rajat Srivastava16 Sep 240.71 Yr.

Data below for TATA India Pharma & Healthcare Fund as on 31 May 25

Equity Sector Allocation
SectorValue
Health Care88.47%
Basic Materials2.37%
Asset Allocation
Asset ClassValue
Cash9.16%
Equity90.84%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Jan 16 | SUNPHARMA
12%₹143 Cr854,300
Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 31 Dec 16 | APOLLOHOSP
6%₹77 Cr111,255
↑ 10,000
Cipla Ltd (Healthcare)
Equity, Since 30 Apr 20 | CIPLA
6%₹72 Cr490,000
Aurobindo Pharma Ltd (Healthcare)
Equity, Since 30 Apr 20 | AUROPHARMA
6%₹71 Cr615,100
Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB
6%₹69 Cr104,965
Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Oct 20 | FORTIS
5%₹60 Cr855,100
Lupin Ltd (Healthcare)
Equity, Since 30 Nov 17 | LUPIN
5%₹59 Cr303,240
Aster DM Healthcare Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Dec 22 | ASTERDM
4%₹54 Cr956,991
Wockhardt Ltd (Healthcare)
Equity, Since 31 Mar 24 | WOCKPHARMA
3%₹40 Cr274,871
Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 18 | DRREDDY
3%₹39 Cr311,555

9. IDBI Small Cap Fund

The Investment objective of the Scheme is to provide investors with the opportunities for long-term capital appreciation by investing predominantly in Equity and Equity related instruments of Small Cap companies. However there can be no assurance that the investment objective under the Scheme will be realized.

IDBI Small Cap Fund is a Equity - Small Cap fund was launched on 21 Jun 17. It is a fund with Moderately High risk and has given a CAGR/Annualized return of 14.9% since its launch.  Return for 2024 was 40% , 2023 was 33.4% and 2022 was 2.4% .

Below is the key information for IDBI Small Cap Fund

IDBI Small Cap Fund
Growth
Launch Date 21 Jun 17
NAV (01 Jul 25) ₹30.585 ↑ 0.00   (0.01 %)
Net Assets (Cr) ₹576 on 31 May 25
Category Equity - Small Cap
AMC IDBI Asset Management Limited
Rating Not Rated
Risk Moderately High
Expense Ratio 2.3
Sharpe Ratio 0.05
Information Ratio -0.61
Alpha Ratio -3.19
Min Investment 5,000
Min SIP Investment 500
Exit Load 0-12 Months (1%),12 Months and above(NIL)

Growth of 10,000 investment over the years.

DateValue
30 Jun 20₹10,000
30 Jun 21₹19,231
30 Jun 22₹20,995
30 Jun 23₹27,082
30 Jun 24₹41,784
30 Jun 25₹40,559

IDBI Small Cap Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹673,113.
Net Profit of ₹373,113
Invest Now

Returns for IDBI Small Cap Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 1 Jul 25

DurationReturns
1 Month 3.1%
3 Month 10%
6 Month -10.9%
1 Year -4.6%
3 Year 24.5%
5 Year 32.2%
10 Year
15 Year
Since launch 14.9%
Historical performance (Yearly) on absolute basis
YearReturns
2024 40%
2023 33.4%
2022 2.4%
2021 64.7%
2020 19%
2019 -4.4%
2018 -15%
2017
2016
2015
Fund Manager information for IDBI Small Cap Fund
NameSinceTenure
Nikhil Rungta1 Jul 240.92 Yr.
Mahesh Bendre1 Jul 240.92 Yr.

Data below for IDBI Small Cap Fund as on 31 May 25

Equity Sector Allocation
SectorValue
Industrials29.89%
Consumer Cyclical17.72%
Basic Materials13.84%
Consumer Defensive8.73%
Utility6.59%
Financial Services6.47%
Technology6.16%
Health Care3.85%
Communication Services2.83%
Real Estate0.41%
Asset Allocation
Asset ClassValue
Cash3.51%
Equity96.49%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Sanathan Textiles Ltd (Consumer Cyclical)
Equity, Since 31 Dec 24 | SANATHAN
3%₹18 Cr390,711
↓ -10,540
JTL Industries Ltd (Basic Materials)
Equity, Since 31 Jul 24 | 534600
3%₹17 Cr2,506,932
Housing & Urban Development Corp Ltd (Financial Services)
Equity, Since 31 Oct 24 | HUDCO
3%₹16 Cr668,754
↓ -42,908
Manorama Industries Ltd (Consumer Defensive)
Equity, Since 31 Dec 24 | 541974
3%₹16 Cr109,106
↓ -6,221
Concord Enviro Systems Ltd (Utilities)
Equity, Since 31 Dec 24 | CEWATER
3%₹16 Cr270,441
Enviro Infra Engineers Ltd (Industrials)
Equity, Since 30 Nov 24 | EIEL
2%₹13 Cr553,566
↑ 44,921
International Gemmological Institute (India) Ltd (Basic Materials)
Equity, Since 31 Dec 24 | IGIL
2%₹13 Cr337,832
Allied Blenders and Distillers Ltd (Consumer Defensive)
Equity, Since 31 Jul 24 | ABDL
2%₹13 Cr326,140
Hindustan Foods Ltd (Industrials)
Equity, Since 31 Jul 24 | 519126
2%₹13 Cr236,195
↑ 16,141
Navkar Corp Ltd (Industrials)
Equity, Since 31 Jul 24 | NAVKARCORP
2%₹13 Cr1,130,075
↑ 45,798

10. L&T Midcap Fund

To generate capital appreciation by investing primarily in midcap stocks. The scheme will invest primarily in companies whose market capitalization falls between the highest and the lowest constituent of the Nifty Free Float Midcap 100.

L&T Midcap Fund is a Equity - Mid Cap fund was launched on 9 Aug 04. It is a fund with High risk and has given a CAGR/Annualized return of 19.3% since its launch.  Ranked 5 in Mid Cap category.  Return for 2024 was 39.7% , 2023 was 40% and 2022 was 1.1% .

Below is the key information for L&T Midcap Fund

L&T Midcap Fund
Growth
Launch Date 9 Aug 04
NAV (01 Jul 25) ₹395.818 ↓ -0.11   (-0.03 %)
Net Assets (Cr) ₹11,470 on 31 May 25
Category Equity - Mid Cap
AMC L&T Investment Management Ltd
Rating
Risk High
Expense Ratio 1.77
Sharpe Ratio 0.2
Information Ratio -0.25
Alpha Ratio -0.69
Min Investment 5,000
Min SIP Investment 500
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

DateValue
30 Jun 20₹10,000
30 Jun 21₹16,076
30 Jun 22₹15,586
30 Jun 23₹19,174
30 Jun 24₹31,208
30 Jun 25₹33,257

L&T Midcap Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹598,181.
Net Profit of ₹298,181
Invest Now

Returns for L&T Midcap Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 1 Jul 25

DurationReturns
1 Month 5.8%
3 Month 16.9%
6 Month -3%
1 Year 6.6%
3 Year 28.7%
5 Year 27.2%
10 Year
15 Year
Since launch 19.3%
Historical performance (Yearly) on absolute basis
YearReturns
2024 39.7%
2023 40%
2022 1.1%
2021 30.4%
2020 19%
2019 -0.2%
2018 -12%
2017 52.3%
2016 9.8%
2015 10.8%
Fund Manager information for L&T Midcap Fund
NameSinceTenure
Cheenu Gupta26 Nov 222.51 Yr.
Sonal Gupta1 Oct 231.67 Yr.

Data below for L&T Midcap Fund as on 31 May 25

Equity Sector Allocation
SectorValue
Industrials22.95%
Financial Services22.02%
Consumer Cyclical20.17%
Health Care12.43%
Technology10.13%
Consumer Defensive4.08%
Basic Materials2.61%
Communication Services1.89%
Utility1.64%
Real Estate0.58%
Asset Allocation
Asset ClassValue
Cash1.51%
Equity98.49%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
BSE Ltd (Financial Services)
Equity, Since 30 Apr 24 | BSE
5%₹533 Cr1,994,300
↓ -406,600
Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 30 Sep 21 | MAXHEALTH
4%₹490 Cr4,355,000
Dixon Technologies (India) Ltd (Technology)
Equity, Since 30 Apr 24 | DIXON
4%₹448 Cr304,800
Eternal Ltd (Consumer Cyclical)
Equity, Since 31 Mar 24 | 543320
4%₹419 Cr17,596,500
Jubilant Foodworks Ltd (Consumer Cyclical)
Equity, Since 31 Mar 25 | 533155
4%₹410 Cr6,248,000
↑ 3,530,506
GE Vernova T&D India Ltd (Industrials)
Equity, Since 30 Sep 24 | 522275
3%₹401 Cr1,790,330
Trent Ltd (Consumer Cyclical)
Equity, Since 30 Jun 19 | TRENT
3%₹385 Cr681,700
Nippon Life India Asset Management Ltd Ordinary Shares (Financial Services)
Equity, Since 30 Apr 24 | NAM-INDIA
3%₹384 Cr5,181,300
↑ 1,674,700
Godfrey Phillips India Ltd (Consumer Defensive)
Equity, Since 31 Jan 19 | GODFRYPHLP
3%₹326 Cr374,885
Persistent Systems Ltd (Technology)
Equity, Since 30 Nov 22 | PERSISTENT
3%₹323 Cr573,700
↓ -153,400

Disclaimer:
यहां प्रदान की गई जानकारी सटीक है, यह सुनिश्चित करने के लिए सभी प्रयास किए गए हैं। हालांकि, डेटा की शुद्धता के संबंध में कोई गारंटी नहीं दी जाती है। कृपया कोई भी निवेश करने से पहले योजना सूचना दस्तावेज के साथ सत्यापित करें।
How helpful was this page ?
POST A COMMENT